0000000000337360

AUTHOR

Andrea Clocchiatti

showing 1 related works from this author

Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER⁺ breast tumors.

2013

MEF2s transcription factors and class IIa HDACs compose a fundamental axis for several differentiation pathways. Functional relationships between this axis and cancer are largely unexplored. We have found that class IIa HDACs are heterogeneously expressed and display redundant activities in breast cancer cells. Applying gene set enrichment analysis to compare the expression profile of a list of putative MEF2 target genes, we have discovered a correlation between the down-regulation of the MEF2 signature and the aggressiveness of ER(+) breast tumors. Kaplan-Meier analysis in ER(+) breast tumors evidenced an association between increased class IIa HDACs expression and reduced survival. The im…

Mef2Nerve growth factor IBTranscription GeneticCell SurvivalApoptosisBreast NeoplasmsBiologyBiochemistryGene Expression Regulation EnzymologicHistone DeacetylasesTranscription (biology)BREAST CANCERCell Line TumorGeneticsNuclear Receptor Subfamily 4 Group A Member 1Gene silencingHumansGene SilencingMolecular BiologyPsychological repressionTranscription factorHDAC4BREAST CANCER; ERPrognosisNeoplasm ProteinsHDAC4; MEF2; BREAST CANCERGene Expression Regulation NeoplasticERMyogenic Regulatory FactorsReceptors EstrogenApoptosisCell cultureCancer researchFemaleMEF2BiotechnologyFASEB journal : official publication of the Federation of American Societies for Experimental Biology
researchProduct